Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Cancer|March 13, 2023
Different treatment efficacies and T790M acquisition of EGFR-TKIs on NSCLC patients with variable Del-19 subtypes of EGFRShang-Gin Wu, Chien-Hung Gow, Yi-Ling Chen, et al.
Genes, Chromosomes & Cancer|January 8, 2017
Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomasChien-Hung Gow, Hou-Tai Chang, Chor-Kuan Lim, et al.
Minerva Anestesiologica|December 7, 2019
Regional air trapping in acute exacerbation of obstructive lung diseases measured with electrical impedance tomography: a feasibility studyZhanqi Zhao, Mei-Yun Chang, Inéz Frerichs, et al.
Journal of Clinical Monitoring and Computing|October 7, 2019
The incidence and interpretation of large differences in EIT-based measures for PEEP titration in ARDS patientsZhanqi Zhao, Li-Chung Lee, Mei-Yun Chang, et al.
The Journal of Biological Chemistry|December 19, 2014
The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2Chun Guo, Yali Li, Chien-Hung Gow, et al.
Annals of Intensive Care|January 19, 2019
Positive end-expiratory pressure titration with electrical impedance tomography and pressure-volume curve in severe acute respiratory distress syndromeZhanqi Zhao, Mei-Ying Chang, Mei-Yun Chang, et al.
Molecular Therapy. Nucleic Acids|November 24, 2020
miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB PathwayYi-Nan Liu, Meng-Feng Tsai, Shang-Gin Wu, et al.
International Journal of Cancer|June 5, 2019
Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancerYi-Nan Liu, Meng-Feng Tsai, Shang-Gin Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment responseJenn-Yu Wu, Shang-Gin Wu, Chih-Hsin Yang, et al.
Cancer Medicine|May 22, 2023
MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasisTzu-Hsiu Tsai, Chien-Hung Gow, Yi-Nan Liu, et al.
Pageof 3